Showing results (251-260 of 597) with videos related to

Sort By:
Pageof 60
Cancer Diagnosis & Prognosis|September 6, 2023
Septic Cervicofacial Phlegmon Following Basal Cell Carcinoma Excision: Life-threatening Complication of Routine Operation in Maxillofacial Surgery?Florian Dudde, Filip Barbarewicz, Kai-Olaf Henkel
Cancer Diagnosis & Prognosis|September 6, 2023
The Number of Colon Crypts in Digital Mucosal Samples: A New Independent Parameter for Diagnosing Ulcerative ColitisCarlos A Rubio, Corinna Lang-Schwarz, Christian Matek, et al.
Cancer Diagnosis & Prognosis|September 6, 2023
Distress Scores During Radiotherapy for Lung Cancer: Course and Prognostic FactorsDirk Rades, Cansu Delikanli, Stefan Janssen, et al.
Cancer Diagnosis & Prognosis|September 6, 2023
Bone Metastases in Renal Cell Carcinoma: Impact of Immunotherapy on SurvivalElisabetta Gambale, Valeria Emma Palmieri, Virginia Rossi, et al.
Cancer Diagnosis & Prognosis|September 6, 2023
Circulating Plasma Cell-free DNA (cfDNA) as a Predictive Biomarker for Radiotherapy: Results from a Prospective Trial in Head and Neck CancerMichael I Koukourakis, Erasmia Xanthopoulou, Ioannis M Koukourakis, et al.
Cancer Diagnosis & Prognosis|January 4, 2024
Neutrophil-to-Lymphocyte Ratio Predicts Immune-related Adverse Events in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus BevacizumabAkifumi Kuwano, Masayoshi Yada, Kosuke Tanaka, et al.
Cancer Diagnosis & Prognosis|March 4, 2024
Clinical Outcomes in Patients With DLBCL Treated With R-CHOP According to Radiotherapy and Interim PET ResponseJesang Yu, Sung Ui Jung, Jin Hyuk Choi, et al.
Cancer Diagnosis & Prognosis|March 4, 2024
Preoperative Myosteatosis and Prognostic Nutritional Index Predict Survival in Older Patients With Resected Biliary Tract CancerMasashi Utsumi, Masaru Inagaki, Koji Kitada, et al.
Cancer Diagnosis & Prognosis|March 4, 2024
Systemic Chemotherapy for Advanced Hepatocellular Carcinoma in Patients With Child-Pugh class BAkifumi Kuwano, Masayoshi Yada, Kosuke Tanaka, et al.
Cancer Diagnosis & Prognosis|March 4, 2024
NK and T-lymphocyte Kinetics Predict Outcome in Myeloma Patients Treated With Elotuzumab, Lenalidomide Plus DexamethasoneKazuhito Suzuki, Morio Matsumoto, Yasushi Hiramatsu, et al.
Pageof 60